PUMP STUDY MDI [multiple daily injection] Lantus/Lispro vs Continuous Insulin+Lispro

Trial Profile

PUMP STUDY MDI [multiple daily injection] Lantus/Lispro vs Continuous Insulin+Lispro

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2009

At a glance

  • Drugs Insulin glargine; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top